Evidence map›Paper›PMID 40887602›Full record

ArticleAddiction science & clinical practice2025

Three trajectories of implementation of medications for opioid use disorder in primary care.

Wayne Kepner, Noel Vest, Emma Risner, Hannah Cheng, Brian Hurley, Hannah Snyder, Mark McGovern

Abstract read
In one paragraph

Article in Addiction science & clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wayne KepnerDivision of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA. wkepner@stanford.edu.
Noel VestDepartment of Community Health Sciences, School of Public Health, Boston University, Boston, MA, USA.
Emma RisnerDepartment of Biostatistics, School of Public Health, Boston University, Boston, MA, USA.
Hannah ChengStanford Center for Dissemination and Implementation, Stanford University School of Medicine, Palo Alto, CA, USA.
Brian HurleyDepartment of Family Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Hannah SnyderDepartment of Family Community Medicine, University of California, San Francisco, San Francisco, CA, USA.
Mark McGovernDivision of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.

Funding

Transforming health equity rhetoric to rigor: Development and validation of a novel measure assessing health equity in implementation of health interventionsP50DA054072 · NIDA · STANFORD UNIVERSITY · PI Mark P McGovern · 2022 to 2026
$18.1M
Interdisciplinary Research Training in Pain and Substance Use DisordersT32DA035165 · NIDA · STANFORD UNIVERSITY · PI SEAN C MACKEY · 2013 to 2026
$7.2M
BUSPH Interdisciplinary Training Program for BiostatisticiansT32GM140972 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Kathryn L Lunetta, Laura Forsberg White · 2021 to 2026
$1.9M
NIDA NIH HHS L30 DA056944NIDA NIH HHS P50 DA054072NIDA NIH HHS T32 DA035165NIGMS NIH HHS T32 GM140972NIH HHS L30DA056944NIH HHS P50DA054072NIH HHS T32DA035165NIH HHS T32GM140972SAMHSA HHS 18-95529
6 · The paper itself

Abstract

backgroundThe opioid epidemic has prompted nationwide efforts to expand access to medications for opioid use disorder (MOUD). Primary care settings have been identified as a critical access point for patients who may benefit from MOUD treatments. Despite implementation efforts, there is limited understanding of how MOUD practice capability in primary care settings evolves over time or what factors influence clinic-level implementation trajectories.

methodsWe conducted a longitudinal study of 95 primary care clinics in California from 2019 to 2024. MOUD practice capability was measured using the Integrating Medications for Addiction Treatment in Primary Care (IMAT-PC) index across three timepoints. Using latent class growth analysis, we analyzed implementation growth trajectories and examined their associations with clinic characteristics and MOUD implementation outcomes (e.g., patient reach and provider adoption).

resultsThree distinct implementation trajectory classes emerged: elevated improving (41.0%), moderate improving (47.4%), and low improving (11.6%). All clinics demonstrated improvements in MOUD practice capability over time. Elevated improving clinics primarily consisted of smaller clinics (< 15,000 patients) and achieved significantly higher number of patients receiving MOUD compared to moderate (p = 0.03) and low improving clinics (p = 0.04). Clinics serving medically underserved populations disproportionately represented the low improving class (p < 0.01). Increase in the number of providers prescribing MOUD did not differ significantly across trajectory classes.

conclusionsAlthough all clinics increased MOUD capability, we found significant associations between implementation trajectory classes and changes in patients receiving MOUD over time in primary care-based MOUD programs. Implementation supports may be more effective and efficient if selected and delivered based upon clinic contextual factors, particularly in resource-constrained and underserved settings.

Indexed as

Opiate Substitution TreatmentOpioid-Related DisordersPrimary Health CareBuprenorphineCaliforniaHumansLongitudinal StudiesBuprenorphineBuprenorphineImplementation scienceLatent class trajectory analysisMedication for opioid use disorderPrimary health care

Identifiers

PMID40887602
PMCPMC12400756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.